Skip to main content
. 2021 Jan 12;13:319–327. doi: 10.2147/CMAR.S280470

Table 3.

Univariable Analysis Predicting OS in Stage IV Breast Cancer Patients

Variable N HR (95% CI) P value
Surgery (yes vs no) 243 0.53 (0.36–0.86) 0.002
Age (<50 vs ≥50 yr) 243 1.12(0.75–1.27) 0.709
Bone metastasis 243 0.84 (0.63–1.63) 0.746
Visceral organ metastasis 243 2.15 (1.22–3.86) 0.000
Number of metastases(continuous) 243 1.24(0.69–1.54) 0.054
ER(+ vs.-) 243 0.66 (0.59–0.94) 0.001
PR(+ vs.-) 243 0.73 (0.58–0.82) 0.029
HER2(+ vs.-) 243 1.46 (0.62–1.83) 0.065

Abbreviations: HR, hazard ratio; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor 2.